Fragility fractures: the clinical pathway
- 18 September 2013
- journal article
- research article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (S1) , 43-45
Abstract
The clinical management of fragility fracture is simple but complex at the same time. Patients are different from one another, and advancing age increases the prevalence of comorbidities and conditions that can impair bone quality and healing, while increasing the risk of falls and fractures. Keeping in mind some principles and key points can help identify patients at risk, thus following an ideal path for the identification, treatment and prevention of fragility fractures.Keywords
This publication has 10 references indexed in Scilit:
- Screening for osteoporosis reduced new fracture incidence by almost halfActa Orthopaedica, 2012
- Short-term and Long-term Orthopaedic Issues in Patients With Fragility FracturesClinical Orthopaedics and Related Research, 2011
- Benefit–risk assessment of vitamin D supplementationOsteoporosis International, 2009
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Vitamin D Status Predicts Physical Performance and Its Decline in Older PersonsThe Journal of Clinical Endocrinology & Metabolism, 2007
- Secondary Osteoporosis: A Review of The Recent EvidenceEndocrine Practice, 2006
- An overview of the prevalence of 25‐hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United KingdomCurrent Medical Research and Opinion, 2006
- The osteoporosis care gap in CanadaBMC Musculoskeletal Disorders, 2004
- Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a FractureArchives of internal medicine (1960), 2003